Cystatin C, Albuminuria, and 5-Year All-Cause Mortality in HIV-Infected Persons
Andy I. Choi(San Francisco VA Medical Center), Michael G. Shlipak(San Francisco VA Health Care System), Lynda A. Szczech(Clinical Research Institute), Carl Grünfeld(University of California, San Francisco), Peter Bacchetti(University of California, San Francisco), Michael S. Saag(University of North Carolina at Chapel Hill), Phyllis C. Tien(San Francisco VA Medical Center), Cynthia L. Gibert(George Washington University), Rebecca Scherzer(San Francisco VA Health Care System)
Cited by 109
Related Papers
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
Cystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons
|New England Journal of Medicine|2005|1.2k
Treatment for Adult HIV Infection
|JAMA|2006|1k
Antiretroviral Therapy in Adults
|JAMA|2000|1k
Antiretroviral Therapy for HIV Infection in 1998
|JAMA|1998|1k